Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by ifsoon Sep 25, 2016 8:06pm

151 Views

Post# 25276516

RE:would appreciate any feed back .

skyhigh123 wrote:

ClinicalTrials.gov Identifier:

NCT02579603

First received: October 16, 2015

Last updated: September 19, 2016

Last verified: September 2016

History of Changes

Sky

Sky, click on the link "history of changes" in your own message. On the page you will get, click on the link "changes for" in line with 2016/09/16. On the top left part of the page you will get, click on the boxe next to "HIide non-essentials portion" in order to see those "non essentials portions". Then you will see those changes.
Ifso

Bullboard Posts

Immigration technology stock CanPR begins trading on the TSXV